Authors’ Reply – Comments: Serum Levels of Infliximab in Brazilian Patients With Crohn’s Disease: What Are the Reasons for Differences from Previous Studies?. Clinics 2019, 74, e1517. https://doi.org/10.6061/clinics/2019/e1517.